Impact of the IASLC Grading and Other Pathological Features on Relapse and Survival in Completely Resected Lung Adenocarcinoma by EGFR Mutation Status: A Supplementary Analysis of the CReGYT‐01 EGFR Study

Documenti analoghi

• Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination
  di: Qing Wu, et al.
  Pubblicazione: (2026)
• EGFR amplification indicated poor prognosis in EGFR‐mutated lung cancer with leptomeningeal metastases
  di: Di Geng, et al.
  Pubblicazione: (2024)
• Sacituzumab tirumotecan improved survival for patients with EGFR TKI–resistant, EGFR‐mutant advanced NSCLC
  di: Leah Lawrence
  Pubblicazione: (2026)
• Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations
  di: Yuko Iida, et al.
  Pubblicazione: (2026)
• Glioblastoma Cells Expressing Oncogenic EGFR Release Multiple Extracellular Vesicle Subpopulations Positive or Negative for EGFR
  di: Elham Pishavar, et al.
  Pubblicazione: (2026)